Your browser doesn't support javascript.
loading
The correlation in echocardiogram to right heart catheterization in identifying pulmonary hypertension as a barrier to liver transplantation.
Hegazy, Yassmin; Aryan, Mahmoud; Panchani, Nishah; Reif, Meagan; Granade, Joseph; Beasley, Mark; Shoreibah, Mohamed.
Afiliación
  • Hegazy Y; University of Alabama Birmingham Hospital, Department of Internal Medicine, Birmingham, AL, USA. Electronic address: yassminhegazy@uabmc.edu.
  • Aryan M; University of Alabama Birmingham Hospital, Department of Internal Medicine, Birmingham, AL, USA.
  • Panchani N; University of Alabama Birmingham Hospital, Department of Internal Medicine, Birmingham, AL, USA.
  • Reif M; University of Alabama Birmingham Hospital, Department of Internal Medicine, Birmingham, AL, USA.
  • Granade J; University of Alabama Birmingham Hospital, Department of Internal Medicine, Birmingham, AL, USA.
  • Beasley M; University of Alabama Birmingham Hospital, Department of Public Health, Birmingham, AL, USA.
  • Shoreibah M; University of Alabama Birmingham Hospital, Department of Gastroenterology and Hepatology, Birmingham, AL, USA.
Am J Med Sci ; 365(6): 496-501, 2023 06.
Article en En | MEDLINE | ID: mdl-36933862
BACKGROUND: Pulmonary hypertension (PH) and portopulmonary hypertension (POPH) can be limitations towards listing for liver transplantation (LT). Our study evaluates the correlation of right ventricular systolic pressure (RVSP) and mean pulmonary artery pressure (mPAP) on transthoracic echocardiogram (TTE) compared to mPAP on right heart catheterization (RHC). METHODS: We performed a retrospective review of 723 patients who underwent LT evaluation at our institution between 2012 and 2020. Our cohort consisted of patients with RVSP and mPAP measured on TTE. A Wald t-test and area under the curve analysis were used for statistical analyses. RESULTS: Patients with higher mPAP values on TTE (N=33) did not correlate with mPAP ≥ 35 mmHg on RHC, while patients with higher RVSP values (N=147) on TTE were associated with mPAP ≥ 35 mmHg on RHC. The cutoff value of RVSP ≥ 48 mmHg on TTE was associated with mPAP ≥ 35 mmHg on RHC. CONCLUSIONS: Our data suggest that RVSP compared to mPAP on TTE is a better indicator for mPAP ≥ 35 mmHg on RHC. RVSP can be used as a marker on echocardiography for identifying patients with a higher likelihood of PH being a barrier to LT listing.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Hígado / Hipertensión Pulmonar Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Med Sci Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Hígado / Hipertensión Pulmonar Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Med Sci Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos